Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: ibrutinib | Statement: [Bruton tyrosine kinase, isTherapeuticTargetOf, ibrutinib]

Target entity: ibrutinib
Context triple: [Bruton tyrosine kinase, isTherapeuticTargetOf, ibrutinib]

• A. Imbruvica chosen
  Imbruvica is a targeted cancer therapy (a Bruton's tyrosine kinase inhibitor) used primarily to treat certain types of blood cancers such as mantle cell lymphoma and chronic lymphocytic leukemia.
• B. Venclexta
  Venclexta is a targeted cancer therapy (venetoclax) used primarily to treat certain types of leukemia by inhibiting the BCL-2 protein that helps cancer cells survive.
• C. Tecentriq
  Tecentriq is an immunotherapy cancer drug (atezolizumab) that targets the PD-L1 protein to help the immune system attack tumors in various cancers.
• D. Verzenio
  Verzenio is a prescription cancer medication (abemaciclib) used primarily to treat certain types of hormone receptor–positive, HER2-negative breast cancer.
• E. Vitrakvi
  Vitrakvi is a targeted cancer therapy (larotrectinib) used to treat solid tumors that have a specific NTRK gene fusion, regardless of the tumor’s location in the body.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target predicate: isTherapeuticTargetOf
Context triple: [Bruton tyrosine kinase, isTherapeuticTargetOf, ibrutinib]

• A. hasMolecularTarget chosen
  Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
• B. regulatoryTarget
  Indicates that one entity is subject to control, influence, or governance by another entity under a regulatory or rule-based framework.
• C. hasTargetDisease
  Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
• D. targetsGene
  Indicates that one entity is directed toward, acts upon, or is intended to affect a specific gene.
• E. potentialTherapeuticUse
  Indicates that something is being considered or investigated as a possible treatment or therapy for a condition or disease.
• F. None of above.